SELE and neoplasm: E-selectin antibody pre-injection resulted in a significant reduction in ESTA-1 binding to tumor vasculature as compared to untreated mice, whereas pre-injection of control IgG did not cause any changes (Fig. 4), suggesting that ESTA-1 binds to E-selectin on the tumor vasculature.